- All sections
- A - Human necessities
- A61L - Methods or apparatus for sterilising materials or objects in general; disinfection, sterilisation or deodorisation of air; chemical aspects of bandages, dressings, absorbent pads or surgical articles; materials for bandages, dressings, absorbent pads or surgical articles
- A61L 24/10 - Polypeptides; Proteins
Patent holdings for IPC class A61L 24/10
Total number of patents in this class: 598
10-year publication summary
43
|
46
|
50
|
64
|
53
|
40
|
49
|
36
|
45
|
12
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Baxter International Inc. | 2425 |
42 |
Ethicon, Inc. | 1310 |
41 |
Baxter Healthcare S.A. | 1810 |
35 |
Omrix Biopharmaceuticals Ltd. | 159 |
19 |
National Institute for Materials Science | 1108 |
12 |
RegenLab USA LLC | 65 |
11 |
University of Utah Research Foundation | 1737 |
9 |
Guangzhou Bioseal Biotech Co., Ltd. | 29 |
9 |
Cook Biotech Incorporated | 212 |
7 |
Takeda Pharmaceutical Company Limited | 2961 |
7 |
3-D Matrix, Ltd. | 116 |
7 |
Ferrosan Medical Devices A/S | 76 |
7 |
Warsaw Orthopedic, Inc. | 3184 |
6 |
Cook Medical Technologies LLC | 3369 |
6 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 2912 |
6 |
Vivex Biologics Group, Inc. | 164 |
6 |
Bard Shannon Limited | 39 |
5 |
Haemostatix Limited | 17 |
5 |
Symbiox, Inc. | 15 |
5 |
Covidien LP | 10647 |
4 |
Other owners | 349 |